Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor of Orthopaedic and Tropical Surgery and Consultant Orthopaedic and Spine Surgeon Chris Lavy has been awarded a prestigious honorary fellowship by the British Orthopaedic Association (BOA).

Photo of Chris Lavy

An Honorary Fellowship is the highest honour that the BOA offer, and is awarded to individuals who have made outstanding contributions to trauma and orthopaedics.

Professor Lavy's clinical interests include surgery of the spine, hip and knee, and his research interests focus on surgery in Africa and the Tropics. He leads the NDORMS Lavy Global Surgery group which is deeply involved in research, teaching and training to strengthen surgical care and training capacity in Africa. This includes SURG-AFRICA, which is focused on scaling up safe surgery in district hospitals to make it accessible to otherwise neglected rural populations, and clubfoot training and research to help to improve treatment for children born with clubfoot in Africa.

One of his newest emerging areas of research is into treatments that could improve the recovery rate from spinal cord injuries.

Candidates for Honorary Fellowships are considered annually by a Board comprising the last five BOA Presidents and usually presented to recipients by the President at the annual BOA Congress.

Due to the coronavirus pandemic, Prof Lavy was presented with the award virtually at this year's BOA conference, and will receive the award in person at the BOA Congress in Aberdeen next September.

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.

Building a humanoid bioreactor

A humanoid robot is being used at NDORMS in an attempt to grow tendon tissue for repairing shoulder injuries.